The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity.
Open accessAbstract
The development and neoplastic progression of human astrocytic tumors appears to result through an accumulation of genetic alterations occurring in a relatively defined order. One such alteration is amplification of the epidermal growth factor receptor (EGFR) gene. This episomal amplification occurs in 40-50% of glioblastomas, which also normally express endogenous receptors. Moreover, a significant fraction of amplified genes are rearranged to specifically eliminate a DNA fragment containing exons 2-7 of the gene, resulting in an in-frame deletion of 801 bp of the coding sequence of the extracellular domain. Here we used retroviral transfer of such a mutant receptor (de 2-7 EGFR) into glioblastoma cells expressing normal endogenous receptors to test whether the mutant receptor was able to augment their growth and malignancy. Western blotting analysis showed that these cells expressed endogenous EGFR of 170 kDa as well as the exogenous de 2-7 EGFR of 140-155 kDa. Although holo-EGFRs were phosphorylated on tyrosine residues only after exposure of the cells to ligand, de 2-7 EGFRs were constitutively phosphorylated. In tissue culture neither addition of EGF nor expression of the mutant EGFR affected the rate of cell growth. However, when cells expressing mutant EGFR were implanted into nude mice subcutaneously or intracerebrally, tumorigenic capacity was greatly enhanced. These results suggest that a tumor-specific alteration of the EGFR plays a significant role in tumor progression perhaps by influencing interactions of tumor cells with their microenvironment in ways not easily assayed in vitro.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genetic Alterations during Colorectal-Tumor Development
Vogelstein, B., Fearon, E. R., Hamilton, S. R., Kern, S. E., Preisinger, A. C., Leppert, M., Smits, A. M. M., & Bos, J. L. (1988) · New England Journal of Medicine · doi:10.1056/nejm198809013190901 · Cited by 6,728
Nowell, P. C. (1976) · Science · doi:10.1126/science.959840 · Cited by 6,471
Signal transduction by receptors with tyrosine kinase activity
Ullrich, A., & Schlessinger, J. (1990) · Cell · doi:10.1016/0092-8674(90)90801-k · Cited by 5,435
Carpenter, G., & Cohen, S. (1979) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.48.070179.001205 · Cited by 2,909
Ullrich, A., Coussens, L., Hayflick, J. S., Dull, T. J., Gray, A., Tam, A. W., Lee, J., Yarden, Y., Libermann, T. A., Schlessinger, J., et al. (1984) · Nature · doi:10.1038/309418a0 · Cited by 2,752
Carpenter, G., & Cohen, S. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)38983-5 · Cited by 1,622
Libermann, T. A., Nusbaum, H. R., Razon, N., Kris, R., Lax, I., Soreq, H., Whittle, N., Waterfield, M. D., Ullrich, A., & Schlessinger, J. (1985) · Nature · doi:10.1038/313144a0 · Cited by 1,503
Buday, L., & Downward, J. (1993) · Cell · doi:10.1016/0092-8674(93)90146-h · Cited by 1,079
Structural alterations of the epidermal growth factor receptor gene in human gliomas.
Wong, A. J., Ruppert, J. M., Bigner, S. H., Grzeschik, C. H., Humphrey, P. A., Bigner, D. S., & Vogelstein, B. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.7.2965 · Cited by 853
Wong, A. J., Bigner, S. H., Bigner, D. D., Kinzler, K. W., Hamilton, S. R., & Vogelstein, B. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.19.6899 · Cited by 849
Kawamoto, T., Sato, J. D., Le, A., Polikoff, J., Sato, G. H., & Mendelsohn, J. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.5.1337 · Cited by 791
LONG TERM CULTURE OF NORMAL AND NEOPLASTIC HUMAN GLIA
PONTÉN, J., & MACINTYRE, E. H. (1968) · Acta Pathologica Microbiologica Scandinavica · doi:10.1111/j.1699-0463.1968.tb03502.x · Cited by 720
Autophosphorylation sites on the epidermal growth factor receptor
Downward, J., Parker, P., & Waterfield, M. D. (1984) · Nature · doi:10.1038/311483a0 · Cited by 704
Clonal expansion of p53 mutant cells is associated with brain tumour progression
Sidransky, D., Mikkelsen, T., Schwechheimer, K., Rosenblum, M. L., Cavanee, W., & Vogelstein, B. (1992) · Nature · doi:10.1038/355846a0 · Cited by 670
Nerve growth factor receptors on human melanoma cells in culture.
Fabricant, R. N., De Larco, J. E., & Todaro, G. J. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.2.565 · Cited by 657
Di Fiore, P. P., Pierce, J. H., Fleming, T. P., Hazan, R., Ullrich, A., King, C. R., Schlessinger, J., & Aaronson, S. A. (1987) · Cell · doi:10.1016/0092-8674(87)90592-7 · Cited by 640
Ekstrand, A. J., Sugawa, N., James, C. D., & Collins, V. P. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.10.4309 · Cited by 602
Sugawa, N., Ekstrand, A. J., James, C. D., & Collins, V. P. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.21.8602 · Cited by 594
Haigler, H., Ash, J. F., Singer, S. J., & Cohen, S. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.7.3317 · Cited by 568
Clonal genomic alterations in glioma malignancy stages.
Cd, J., Carlbom, E., Dumanski, J. P., Hansen, M., Nordenskjöld, M., Collins, V. P., & Cavenee, W. K. (1988) · PubMed · Cited by 512
Self-citationYarden, Y., & Schlessinger, J. (1987) · Biochemistry · doi:10.1021/bi00379a034 · Cited by 507
Gill, G. N., Kawamoto, T., Cochet, C., Le, A., Sato, J. D., Masui, H., McLeod, C., & Mendelsohn, J. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42857-2 · Cited by 455
Self-citationLigand-Induced Transformation by a Noninternalizing Epidermal Growth Factor Receptor
Wells, A., Welsh, J. B., Lazar, C. S., Wiley, H. S., Gill, G. N., & Rosenfeld, M. G. (1990) · Science · doi:10.1126/science.2305263 · Cited by 411
Self-citationHumphrey, P. A., Wong, A. J., Vogelstein, B., Zalutsky, M. R., Fuller, G. N., Archer, G. E., Friedman, H. S., Kwatra, M. M., Bigner, S. H., & Bigner, D. D. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.11.4207 · Cited by 382
A monoclonal antibody to the human epidermal growth factor receptor
Waterfield, M. D., Mayes, E. L. V., Stroobant, P., Bennet, P. L. P., Young, S., Goodfellow, P. N., Banting, G. S., & Ozanne, B. (1982) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240200207 · Cited by 338
Kris, R. M., Lax, I., Gullick, W., Waterfield, M. D., Ullrich, A., Fridkin, M., & Schlessinger, J. (1985) · Cell · doi:10.1016/0092-8674(85)90210-7 · Cited by 295
Fults, D., Brockmeyer, D. L., Tullous, M. W., Pedone, C. A., & Cawthon, R. (1992) · PubMed · Cited by 292
Mitotic recombination of chromosome 17 in astrocytomas.
James, C. D., Carlbom, E., Nordenskjold, M., Collins, V. P., & Cavenee, W. K. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.8.2858 · Cited by 279
Self-citationJaros, E., Perry, R., Adam, L., Kelly, P., Crawford, P., Kalbag, R., Mendelow, A., Sengupta, R., & Pearson, A. (1992) · British Journal of Cancer · doi:10.1038/bjc.1992.273 · Cited by 264
Comparative Study of p53 Gene and Protein Alterations in Human Astrocytic Tumors
Louis, D. N., Deimling, A. V., Chung, R. Y., Rubio, M.-P., Whaley, J. M., Eibl, R. H., Ohgaki, H., Wiestler, O. D., Thor, A. D., & Seizinger, B. R. (1993) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199301000-00005 · Cited by 228
Xu, Y. H., Richert, N., Ito, S., Merlino, G. T., & Pastan, I. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.23.7308 · Cited by 225
Schlegel, J., Merdes, A., Stumm, G., Albert, F. K., Forsting, M., Hynes, N., & Kiessling, M. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910560114 · Cited by 201
Amplification of Epidermal Growth Factor Receptor Gene in Gliomas: Histopathology and Prognosis
Hurt, M. R., Moossy, J., Donovan-Peluso, M., & Locker, J. (1992) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199201000-00010 · Cited by 197
ONCOGENE ACTIVATION BY CHROMOSOME TRANSLOCATION IN HUMAN MALIGNANCY
Haluska, F. G., Tsujimoto, Y., & Croce, C. M. (1987) · Annual Review of Genetics · doi:10.1146/annurev.ge.21.120187.001541 · Cited by 171
Yamazaki, H., Ohba, Y., Tamaoki, N., & Shibuya, M. (1990) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1990.tb02644.x · Cited by 158
Malden, L. T., Novak, U., Kaye, A. H., & Burgess, A. W. (1988) · PubMed · Cited by 156
Protein phosphorylation at tyrosine is induced by the v-erbB gene product in vivo and in vitro
Gilmore, T. D., DeClue, J. E., & Martin, G. S. (1985) · Cell · doi:10.1016/0092-8674(85)90209-0 · Cited by 154
Hunts, J., Ueda, M., Ozawa, S., Abe, O., Pastan, I. H., & Shimizu, N. (1985) · PubMed · Cited by 139
Factors affecting long-term stability of Moloney murine leukemia virus-based vectors
Xu, L., Yee, J. K., Wolff, J. A., & Friedmann, T. (1989) · Virology · doi:10.1016/0042-6822(89)90600-4 · Cited by 128
Cadena, D. L., Chan, C., & Gill, G. N. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42343-x · Cited by 75
Self-citationAnalysis of mammalian fibroblast transformation by normal and mutated human EGF receptors.
Jd, H., Hsuan, J. J., & Waterfield, M. D. (1989) · PubMed · Cited by 54
Maruo, T., Yamasaki, M., Ladines‐Llave, C. A., & Mochizuki, M. (1992) · Cancer · doi:10.1002/cncr.2820690519 · Cited by 51
Callaghan, T., Antczak, M., Flickinger, T. W., Raines, M. A., Myers, M., & Kung, H. J. (1993) · PubMed · Cited by 39
Woltjer, R. L., Lukas, T. J., & Staros, J. V. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.16.7801 · Cited by 38
Wedegaertner, P., & Gill, G. N. (1992) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(92)90079-c · Cited by 15
Self-citation
Cited by
Malignant astrocytic glioma: genetics, biology, and paths to treatment
Furnari, F. B., Fenton, T., Bachoo, R. M., Mukasa, A., Stommel, J. M., Stegh, A., Hahn, W. C., Ligon, K. L., Louis, D. N., Brennan, C., et al. (2007) · Genes & Development · doi:10.1101/gad.1596707 · Cited by 2,316
Self-citationEpidermal growth factor receptor: Mechanisms of activation and signalling
Jorissen, R. (2003) · Experimental Cell Research · doi:10.1016/s0014-4827(02)00098-8 · Cited by 1,565
Status of Epidermal Growth Factor Receptor Antagonists in the Biology and Treatment of Cancer
Mendelsohn, J., & Baselga, J. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.01.504 · Cited by 1,255
Malignant glioma: genetics and biology of a grave matter
Maher, E. A., Furnari, F. B., Bachoo, R. M., Rowitch, D. H., Louis, D. N., Cavenee, W. K., & DePinho, R. A. (2001) · Genes & Development · doi:10.1101/gad.891601 · Cited by 1,229
Self-citationERBB Receptors: From Oncogene Discovery to Basic Science to Mechanism-Based Cancer Therapeutics
Arteaga, C. L., & Engelman, J. A. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.02.025 · Cited by 1,048
“EGFRvIII exhibits constitutive dimerization, impaired downregulation, and aberrant tyrosine kinase activity, all resulting in enhanced tumorigenicity (Nishikawa et al., 1994).”
Background
Metadata
- Authors
- Nishikawa, R., Ji, X. D., Harmon, R. C., Lazar, C. S., Gill, G. N., Cavenee, W. K., & Huang, H. J.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1994-08-02
- Volume
- 91
- Issue
- 16
- Pages
- 7727-7731
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2013878898
- Cited by
- 936
- References
- 45
- FWCI
- 10.34
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.